secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001213900-25-040724
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial raises $2.75M via warrant inducement; existing warrants exercised at $0.74
--------------------------------------------------------------------------------

- Existing Series B and C warrants for 3,718,440 shares exercised at reduced price of $0.74 per share.
- Company issued new unregistered Series B-1 (2.48M shares) and C-1 (4.03M shares) warrants at $0.74 exercise price.
- New warrants exercisable only after stockholder approval; Series B-1 expire in 5 years, C-1 in 18 months.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/0001213900-25-040724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/ea0241155-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-040724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer